Onconova Therapeutics Inc
F:0T2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Onconova Therapeutics Inc
F:0T2
|
US |
|
M
|
Minco Silver Corp
XMUN:XYD
|
CA |
|
S
|
Soligenix Inc
F:DOA2
|
US |
|
A
|
Akastor ASA
DUS:KY7
|
NO |
|
MedPeer Inc
OTC:MDPEF
|
JP |
|
Indra Sistemas SA
OTC:ISMAF
|
ES |
|
A
|
Auroch Minerals Ltd
F:T59
|
AU |
|
Pelatro PLC
F:7ZB
|
UK |
|
B
|
Batm Advanced Communications Ltd
TASE:BVC
|
IL |
|
C
|
Ceps PLC
LSE:CEPS
|
UK |
|
U
|
UTStarcom Holdings Corp
F:UT5A
|
CN |
|
A
|
Astronics Corp
XBER:AC1
|
US |
|
California BanCorp
F:KZ9
|
US |
|
K
|
Kodiak Copper Corp
F:5DD1
|
CA |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
D
|
Downer EDI Ltd
OTC:DNERY
|
AU |
Bankruptcy Probability
Onconova Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Onconova Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Onconova Therapeutics Inc
NASDAQ:TRAW
|
8.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
658.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
375.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
281.5B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Onconova Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Onconova Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
